Abstract
Cardiac valvular pathologies are often caused by rheumatic fever in young adults, atherosclerosis in elderly patients, or by congenital malformation of the heart in children, in effect affecting almost all population ages. Almost 300,000 heart valve operations are performed worldwide annually. Tissue valve prostheses have certain advantages over mechanical valves such as biocompatibility, more physiological hemodynamics, and no need for life-long systemic anticoagulation. However, the major disadvantage of biological valves is related to their durability. Nevertheless, during the last decade, the number of patients undergoing biological, rather than mechanical, valve replacement has increased from half to more than three-quarters for biological implants. Continuous improvement in valve fabrication includes development of new models and shapes, novel methods of tissue treatment, and preservation and implantation techniques. These efforts are focused not only on the improvement of morbidity and mortality of the patients but also on the improvement of their quality of life. Heart valve tissue engineering aims to provide durable, “autologous” valve prostheses. These valves demonstrate adaptive growth, which may avoid the need of repeated operations in growing patients.
References
[1] Aazami M, Schafers HJ. Advances in heart valve surgery. J Interv Cardiol 2003; 16: 535–541.10.1046/j.1540-8183.2003.01053.xSearch in Google Scholar
[2] Acar C, de Ibarra JS, Lansac E. Anterior leaflet augmentation with autologous pericardium for mitral repair in rheumatic valve insufficiency. J Heart Valve Dis 2004; 13: 741–746.Search in Google Scholar
[3] Bortolotti U, Talenti E, Milano A, Thiene G, Gallucci V. Formaldehyde- versus glutaraldehyde-processed porcine bioprostheses in the aortic valve position: long-term follow-up. Am J Cardiol 1984; 54: 681–682.10.1016/0002-9149(84)90279-0Search in Google Scholar
[4] Bruschi G, De Marco F, Martinelli L, Klugmann S. CoreValve(R) transcatheter self-expandable aortic bioprosthesis. Expert Rev Med Devices 2013; 10: 15–26.10.1586/erd.12.64Search in Google Scholar
[5] Carpentier A. Cardiac valve surgery – the “French correction”. J Thorac Cardiovasc Surg 1983; 86: 323–337.10.1016/S0022-5223(19)39144-5Search in Google Scholar
[6] Cebotari S, Lichtenberg A, Tudorache I, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006; 114: I132–I137.10.1161/CIRCULATIONAHA.105.001065Search in Google Scholar PubMed
[7] Cebotari S, Mertsching H, Kallenbach K, et al. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002; 106: I63–I68.10.1161/01.cir.0000032900.55215.85Search in Google Scholar
[8] Cebotari S, Tudorache I, Ciubotaru A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation 2011; 124: S115–S123.10.1161/CIRCULATIONAHA.110.012161Search in Google Scholar PubMed
[9] Cevik C, Izgi C, Dechyapirom W, Nugent K. Treatment of prosthetic valve thrombosis: rationale for a prospective randomized clinical trial. J Heart Valve Dis 2010; 19: 161–170.Search in Google Scholar
[10] Chan V, Lam BK, Rubens FD, et al. Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement. J Thoracic Cardiovasc Surg 2012; 144: 146–151.10.1016/j.jtcvs.2011.08.041Search in Google Scholar PubMed
[11] Chikwe J, Filsoufi F. Durability of tissue valves. Semin Thorac Cardiovasc Surg 2011; 23: 18–23.10.1053/j.semtcvs.2011.04.008Search in Google Scholar PubMed
[12] Cicha I, Ruffer A, Cesnjevar R, et al. Early obstruction of decellularized xenogenic valves in pediatric patients: involvement of inflammatory and fibroproliferative processes. Cardiovasc Pathol 2011; 20: 222–231.10.1016/j.carpath.2010.04.006Search in Google Scholar PubMed
[13] Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 1993; 105: 934–941; discussion 41–42.10.1016/S0022-5223(19)34168-6Search in Google Scholar
[14] Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis 2012; 105: 146–152.10.1016/j.acvd.2012.01.005Search in Google Scholar
[15] da Costa FD, Dohmen PM, Duarte D, et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur J Cardiothorac Surg 2005; 27: 572–578.10.1016/j.ejcts.2004.12.057Search in Google Scholar
[16] Deac RF, Simionescu D, Deac D. New evolution in mitral physiology and surgery: mitral stentless pericardial valve. Ann Thorac Surg 1995; 60: S433–S438.10.1016/0003-4975(95)00303-3Search in Google Scholar
[17] den Hamer I, Hepkema B, Prop J, Elzenga N, Ebels T. HLA antibodies specific for cryopreserved heart valve “homografts” in children. J Thoracic Cardiovasc Surg 1997; 113: 417–419.10.1016/S0022-5223(97)70343-XSearch in Google Scholar
[18] Dohmen PM, Costa F, Lopes SV, et al. Results of a decellularized porcine heart valve implanted into the juvenile sheep model. Heart Surg Forum. 2005; 8: E100–E104; discussion E4.10.1532/HSF98.20041140Search in Google Scholar
[19] Doty JR, Salazar JD, Liddicoat JR, Flores JH, Doty DB. Aortic valve replacement with cryopreserved aortic allograft: ten-year experience. J Thorac Cardiovasc Surg 1998; 115: 371–379; discussion 9–80.10.1016/S0022-5223(98)70281-8Search in Google Scholar
[20] Erez E, Kanter KR, Isom E, Williams WH, Tam VK. Mitral valve replacement in children. J Heart Valve Dis 2003; 12: 25–29; discussion 30.Search in Google Scholar
[21] Farrar EJ, Butcher JT. Valvular heart diseases in the developing world: developmental biology takes center stage. J Heart Valve Dis 2012; 21: 234–240.Search in Google Scholar
[22] Folliguet TA, Laborde F, Zannis K, Ghorayeb G, Haverich A, Shrestha M. Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg 2012; 93: 1483–1488.10.1016/j.athoracsur.2012.01.071Search in Google Scholar
[23] Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg 2001; 72: 577–591.10.1016/S0003-4975(01)02820-XSearch in Google Scholar
[24] Gulbins H, Kreuzer E, Reichart B. Homografts: a review. Expert Rev Cardiovasc Ther 2003; 1: 533–539.10.1586/14779072.1.4.533Search in Google Scholar PubMed
[25] Gummert JF, Funkat A, Beckmann A, et al. Cardiac surgery in Germany during 2007: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2008; 56: 328–336.10.1055/s-2008-1038756Search in Google Scholar
[26] Heimbecker RO, Baird RJ, Lajos TZ, Varga AT, Greenwood WF. Homograft replacement of the human mitral valve. A preliminary report. Can Med Assoc J 1962; 86: 805–809.Search in Google Scholar
[27] Hendriks M, Everaerts F, Verhoeven M. Alternative fixation of bioprostheses. J Long Term Eff Medical Implants 2001; 11: 163–183.10.1615/JLongTermEffMedImplants.v11.i34.60Search in Google Scholar
[28] Hoffmann G, Lutter G, Cremer J. Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int 2008; 105: 143–148.10.3238/arztebl.2008.0143Search in Google Scholar
[29] Ionescu MI, Ross DN. Heart-valve replacement with autologous fascia lata. Lancet 1969; ii: 335–338.10.1016/S0140-6736(69)92696-8Search in Google Scholar
[30] Ionescu MI, Pakrashi BC, Holden MP, Mary DA, Whitaker W, Wooler GH. Results of aortic fascia lata and pericardium valve replacement. Br Heart J 1973; 35: 555.Search in Google Scholar
[31] Ionescu MI, Ross DN, Deac RC, Wooler GH. Heart valve replacement with autologous fascia lata. J Thorac Cardiovasc Surg 1970; 60: 331–354.10.1016/S0022-5223(19)42347-7Search in Google Scholar
[32] Ionescu MI, Ross DN, Wooler GH, Deac R, Ray D. Replacement of heart valves with autologous fascia lata. Surgical technique. Br J Surg 1970; 57: 437–442.10.1002/bjs.1800570609Search in Google Scholar
[33] Ionescu MI, Tandon AP, Mary DA, Abid A. Heart valve replacement with the Ionescu-Shiley pericardial xenograft. J Thorac Cardiovasc Surg 1977; 73: 31–42.10.1016/S0022-5223(19)39979-9Search in Google Scholar
[34] Kallikourdis A, Jacob S. Is a stentless aortic valve superior to conventional bioprosthetic valves for aortic valve replacement? Interact Cardiovasc Thorac Surg 2007; 6: 665–672.10.1510/icvts.2007.160051Search in Google Scholar PubMed
[35] Kobayashi J. Stentless aortic valve replacement: an update. Vasc Health Risk Manage 2011; 7: 345–351.10.2147/VHRM.S11253Search in Google Scholar PubMed PubMed Central
[36] Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686–1695.10.1056/NEJMoa1200384Search in Google Scholar PubMed
[37] Liao K, Seifter E, Hoffman D, Yellin EL, Frater RW. Bovine pericardium versus porcine aortic valve: comparison of tissue biological properties as prosthetic valves. Artif Organs 1992; 16: 361–365.10.1111/j.1525-1594.1992.tb00532.xSearch in Google Scholar
[38] Lichtenberg A, Tudorache I, Cebotari S, et al. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006; 114: I559–I565.10.1161/CIRCULATIONAHA.105.001206Search in Google Scholar
[39] Luciani GB, Santini F, Mazzucco A. Autografts, homografts, and xenografts: overview on stentless aortic valve surgery. J Cardiovasc Med 2007; 8: 91–96.10.2459/01.JCM.0000260208.98246.10Search in Google Scholar
[40] Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 2006; 34: 1799–1819.10.1007/s10439-006-9163-zSearch in Google Scholar
[41] Mohler ER, III, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999; 8: 254–260.Search in Google Scholar
[42] O′Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999; 11: 194–200.Search in Google Scholar
[43] Perri G, Polito A, Esposito C, et al. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur J Cardiothoracic Surg 2012; 41: 1320–1325.10.1093/ejcts/ezr221Search in Google Scholar
[44] Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 2003; 41: 893–904.10.1016/S0735-1097(02)02965-0Search in Google Scholar
[45] Raja SG, Pollock JC. Current outcomes of Ross operation for pediatric and adolescent patients. J Heart Valve Dis 2007; 16: 27–36.Search in Google Scholar
[46] Raja SG, Atamanyuk I, Kostolny M, Tsang V. In young patients with rheumatic aortic regurgitation compared to non-rheumatics is a Ross operation associated with increased incidence of autograft failure? Interact Cardiovasc Thorac Surg 2010; 10: 600–604.10.1510/icvts.2009.229534Search in Google Scholar PubMed
[47] Redlich K, Khaladj N, Peterss S, et al. Conventional aortic valve replacement in patients with concomitant coronary artery disease and previous coronary artery bypass grafting in the era of interventional approaches. Eur J Cardiothorac Surg 2011; 40: 455–462.10.1016/j.ejcts.2010.11.067Search in Google Scholar PubMed
[48] Rieder E, Seebacher G, Kasimir MT, et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005; 111: 2792–2797.10.1161/CIRCULATIONAHA.104.473629Search in Google Scholar PubMed
[49] Ross D. Homograft replacement of the aortic valve. Br J Surg 1967; 54: 842–843.10.1002/bjs.1800541011Search in Google Scholar PubMed
[50] Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967; ii: 956–958.10.1016/S0140-6736(67)90794-5Search in Google Scholar
[51] Ruffer A, Purbojo A, Cicha I, et al. Early failure of xenogenous de-cellularised pulmonary valve conduits – a word of caution! Eur J Cardiothorac Surg 2010; 38: 78–85.10.1016/j.ejcts.2010.01.044Search in Google Scholar
[52] Sawaya F, Stewart J, Babaliaros V. Aortic stenosis: who should undergo surgery, transcatheter valve replacement? Cleve Clin J Med 2012; 79: 487–497.10.3949/ccjm.79a.11043Search in Google Scholar
[53] Schmidt D, Mol A, Odermatt B, et al. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng 2006; 12: 3223–3232.10.1089/ten.2006.12.3223Search in Google Scholar
[54] Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008; 118: 1864–1880.10.1161/CIRCULATIONAHA.108.805911Search in Google Scholar
[55] Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072–1080.10.1016/j.athoracsur.2004.06.033Search in Google Scholar
[56] Schoen FJ, Sutton MS. Contemporary issues in the pathology of valvular heart disease. Hum Pathol 1987; 18: 568–576.10.1016/S0046-8177(87)80356-8Search in Google Scholar
[57] Shinoka T, Breuer CK, Tanel RE, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995; 60: S513–S516.10.1016/0003-4975(95)00733-4Search in Google Scholar
[58] Shrestha M, Folliguet T, Meuris B, et al. Sutureless perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis 2009; 18: 698–702.Search in Google Scholar
[59] Shrestha M, Khaladj N, Bara C, Hoeffler K, Hagl C, Haverich A. A staged approach towards interventional aortic valve implantation with a sutureless valve: initial human implants. Thorac Cardiovasc Surg 2008; 56: 398–400.10.1055/s-2008-1038722Search in Google Scholar
[60] Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003; 23: 1002–1006; discussion 6.10.1016/S1010-7940(03)00094-0Search in Google Scholar
[61] Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187–2198.10.1056/NEJMoa1103510Search in Google Scholar
[62] Spencer FC. Presidential address. Intellectual creativity in thoracic surgeons. J Thorac Cardiovasc Surg 1983; 86: 163–179.10.1016/S0022-5223(19)39172-XSearch in Google Scholar
[63] Sreeram N, Ben Mime L, Bennink G. Pericardial patch valve in the tricuspid position in an infant. Cardiol Young 2011; 21: 458–459.10.1017/S1047951110001903Search in Google Scholar
[64] Stelzer P. The Ross procedure: state of the art 2011. Semin Thorac Cardiovasc Surg 2011; 23: 115–123.10.1053/j.semtcvs.2011.07.003Search in Google Scholar
[65] Thiene G, Valente M. Anticalcification strategies to increase bioprosthetic valve durability. J Heart Valve Dis 2011; 20: 37–44.Search in Google Scholar
[66] Walther T, Kempfert J, Mohr FW. Transcatheter aortic valve implantation: surgical perspectives. Arch Cardiovasc Dis 2012; 105: 174–180.10.1016/j.acvd.2012.02.004Search in Google Scholar
[67] Watkins DA, Zuhlke LJ, Engel ME, Mayosi BM. Rheumatic fever: neglected again. Science 2009; 324: 37.10.1126/science.324.5923.37bSearch in Google Scholar
[68] Yacoub M, Rasmi NR, Sundt TM, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995; 110: 186–193; discussion 93–94.10.1016/S0022-5223(05)80025-XSearch in Google Scholar
[69] Yankah AC, Klose H, Petzina R, Musci M, Siniawski H, Hetzer R. Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience. Eur J Cardiothorac Surg 2002; 21: 260–267.10.1016/S1010-7940(01)01084-3Search in Google Scholar
[70] Yankah AC, Wottge HU, Muller-Hermelink HK, et al. Transplantation of aortic and pulmonary allografts, enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J Card Surg 1987; 2: 209–220.10.1111/jocs.1987.2.1s.209Search in Google Scholar PubMed
[71] Yusuf S, Vaz M, Pais P. Tackling the challenge of cardiovascular disease burden in developing countries. Am Heart J 2004; 148: 1–4.10.1016/j.ahj.2004.03.045Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
